The Baker McKenzie LLP antitrust and competition practice group continues to handle complex merger control mandates, often handling multijurisdictional clearance matters working closely with teams in Europe. Mark Hamer and Creighton Macy co-head the team from Washington DC: global head Hamer draws on experience at the Department of Justice antitrust division to lead on both litigation and mergers, and Macy, chairing the North America practice, takes on cartel and merger investigations. Brian Burke , also in DC, is a go-to for merger clearance matters across the healthcare, tech, chemicals, and telecoms sectors. Nandu Machiraju departed the team in June 2024.
Legal 500 redaktioneller Kommentar
Kernmandanten
- Sika Corporation & Sika AG
- Numab Therapeutics
- PRADA USA
- Dolce & Gabbana
- Polo Ralph Lauren
- Environmental Data Resources
- International Franchise Association
- ALDI
- Chr. Hansen
- Rio Tinto
Highlight-Mandate
- Representing Sika in 19 private damages antitrust class actions now centralized as an MDL proceeding in the Southern District of New York, brought on behalf of direct and indirect purchaser classes.
- Advising Numab Therapeutics in the agreement with Johnson & Johnson to acquire Numab's subsidiary Yellow Jersey Therapeutics which holds its Phase 2-ready NM26 bispecific antibody program for atopic dermatitis for USD 1.25 billion.
- Acting as lead counsel for PRADA in no-poach antitrust litigation in the Eastern District of New York (Brooklyn), Giordano, et al. v. Saks Fifth Avenue, et al.
Anwält*innen
Praxisleitung
Mark Hamer; Creighton Macy
Weitere Kernanwält*innen
Mark Weiss; Brian Burke; Jeff Martino